valine has been researched along with bms 806 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colonno, RJ; Dufour, J; Hu, Q; Ketas, TJ; Klasse, PJ; Lu, M; Marx, PA; Moore, JP; Schader, SM; Shattock, RJ; Springer, MS; Veazey, RS | 1 |
| Towie, N | 1 |
| Ketas, TJ; Klasse, PJ; Lu, M; Moore, JP; Polonis, V; Schader, SM; Teo, E; Zurita, J | 1 |
3 other study(ies) available for valine and bms 806
| Article | Year |
|---|---|
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
Topics: Administration, Intravaginal; Animals; Anti-HIV Agents; CCR5 Receptor Antagonists; CD4 Antigens; Cell Fusion; Drug Therapy, Combination; Female; HIV; HIV Envelope Protein gp120; HIV Infections; Macaca mulatta; Membrane Fusion; Piperazines; Pyrazoles; Receptors, CCR5; Receptors, Virus; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Vagina; Valine | 2005 |
Drug firms donate compounds for anti-HIV gel.
Topics: Administration, Intravaginal; Africa; Animals; Anti-HIV Agents; Clinical Trials as Topic; Drug Industry; Drug Therapy, Combination; Female; Gels; HIV Infections; Humans; Male; Piperazines; Pyrazoles; Valine | 2005 |
Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.
Topics: Animals; Anti-Infective Agents, Local; CCR5 Receptor Antagonists; Drug Evaluation, Preclinical; Drug Interactions; Female; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; In Vitro Techniques; Male; Piperazines; Pyrazoles; Pyridines; Receptors, CXCR4; Sexual Behavior; Valine; Virus Internalization | 2007 |